E-Pill Pharma


Public lists: Medical Devices (6123)

E-Pill Pharma - Develops an "electrical pill" performing electrical nerve stimulation of the intestines (ENSI). ENSI affects the absorption properties of the GI tract membrane.

E-Pill Pharma - Develops an "electrical pill" performing electrical nerve stimulation of the intestines (ENSI). ENSI affects the absorption properties of the GI tract membrane.

Company (Alive / Active)

Phone:

Fax:

2 Hatohen St
Caesarea Industrial Park
38900
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
E-Pill Pharma $0M Nov 30, 2018
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related E-Pill Pharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Neuronetics

Malvern, Pennsylvania, United States
IPO / Went publicNeuronetics is a privately held medical device company focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. Based in Malvern, PA, Neuronetics is the leader in the development of TMS Therapy, a non-invasive form of neuromodulation.Login to see details

Minimus Spine

Austin, Texas, United States
Alive / ActiveMinimus Spine is developing ozone injection technology specifically for spinal applications. The company has improved upon the existing technology through a system that creates ozone, and measures its concentration, within in a sterile, syringe-cartridge. This has advantages in terms of sterility and dose assurance, as well as material compatibility, which are vital to the advancement of this technique.Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)